Black Rock Inc. Ngm Biopharmaceuticals Inc Transaction History

Black Rock Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$1.17 - $1.92 $203,527 - $333,993	-173,955 Reduced 5.47%	3,004,210 $4.78 Million
Q4 2023 Feb 13, 2024	SELL	$0.6 - $1.31 $397,028 - $866,845	-661,714 Reduced 17.23%	3,178,165 $2.73 Million
Q3 2023 Nov 13, 2023	SELL	$1.05 - $3.37 $832,782 - $2.67 Million	-793,126 Reduced 17.12%	3,839,879 $4.11 Million
Q2 2023 Aug 11, 2023	BUY	$2.44 - $4.53 $1.29 Million - $2.39 Million	526,863 Added 12.83%	4,633,005 $12 Million
Q1 2023 May 12, 2023	SELL	$3.72 - $5.4 $199,466 - $289,548	-53,620 Reduced 1.29%	4,106,142 $16.8 Million
Q4 2022 Feb 13, 2023	BUY	$3.41 - $12.93 $317,760 - $1.2 Million	93,185 Added 2.29%	4,159,762 $20.9 Million
Q3 2022 Nov 14, 2022	BUY	$12.59 - $17.67 $2.44 Million - $3.42 Million	193,828 Added 5.0%	4,066,577 $53.2 Million
Q2 2022 Aug 12, 2022	BUY	$10.58 - $17.5 $10.9 Million - $18.1 Million	1,033,075 Added 36.38%	3,872,749 $49.6 Million
Q1 2022 May 12, 2022	BUY	$13.81 - $18.6 $813,174 - $1.1 Million	58,883 Added 2.12%	2,839,674 $43.3 Million
Q4 2021 Feb 10, 2022	BUY	$17.26 - $22.02 $5.8 Million - $7.4 Million	335,959 Added 13.74%	2,780,791 $49.3 Million
Q3 2021 Nov 09, 2021	BUY	$20.15 - $26.19 $2.93 Million - $3.81 Million	145,477 Added 6.33%	2,444,832 $51.4 Million
Q2 2021 Aug 11, 2021	BUY	$15.06 - $30.03 $34.6 Million - $69 Million	2,299,355 New	2,299,355 $45.3 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.